Tarr P E, Kuppens L, Jones T C, Ivanoff B, Aparin P G, Heymann D L
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Am J Trop Med Hyg. 1999 Jul;61(1):163-70. doi: 10.4269/ajtmh.1999.61.163.
We report on the ongoing epidemic of typhoid fever in Tajikistan that started in 1996. It has involved more than 24,000 cases to date, and is characterized by multiple point sources, overflow of sewage, contaminated municipal water, and person-to-person spread. Of the Salmonella typhi isolates available for testing in western laboratories, more than 90% are multidrug-resistant (MDR). Most recently, 28 (82%) of 34 isolates are resistant to ciprofloxacin, representing the first reported epidemic of quinolone-resistant typhoid fever. In the past, mass immunization during typhoid fever epidemics has been discouraged. A review of this policy is recommended in light of the alarming emergence of quinolone-resistant strains of S. typhi, the availability of improved vaccines, and the ongoing epidemic in Tajikistan. Mass immunization may be a useful measure for the control of prolonged MDR typhoid fever epidemics, as an adjunct to correction of municipal infrastructure and public health intervention.
我们报告了1996年开始在塔吉克斯坦持续流行的伤寒热疫情。迄今为止,该疫情已涉及24000多例病例,其特点是存在多个传染源、污水溢流、城市供水受污染以及人传人传播。在西方实验室可用于检测的伤寒杆菌分离株中,超过90%具有多重耐药性(MDR)。最近,34株分离株中有28株(82%)对环丙沙星耐药,这是首次报告的耐喹诺酮伤寒热疫情。过去,伤寒热疫情期间不鼓励进行大规模免疫接种。鉴于耐喹诺酮伤寒杆菌菌株的惊人出现、改良疫苗的可得性以及塔吉克斯坦持续的疫情,建议对这一政策进行审查。作为改善城市基础设施和公共卫生干预措施的辅助手段,大规模免疫接种可能是控制长期多重耐药伤寒热疫情的一项有用措施。